Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroectodermal Tumors, Primitive × Thalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 32 Neoplasms, Plasma Cell 10 Immunoglobulin Light-chain Amyloidosis 3 Central Nervous System Neoplasms 3 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Amyloidosis 2 Adenocarcinoma of Lung 2 Waldenstrom Macroglobulinemia 1 Sarcoma 1 Renal Insufficiency, Chronic 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Polyneuropathies 1 Paraproteinemias 1 Neurotoxicity Syndromes 1 Motor Activity 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

antineoplaston AS 2-1 3 antineoplaston A10 3 dactolisib 2 Temozolomide 2 Irinotecan 2 Everolimus 2 Bevacizumab 2 spartalizumab 1 poly ICLC 1 plerixafor 1 pasireotide 1 fosbretabulin 1 cixutumumab 1 adavosertib 1 Vaccines 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation 1 PM 00104 1 Lapatinib 1 Immunologic Techniques 1 Immunoglobulin G 1 Genistein 1 Fentanyl 1 Donepezil 1 Disulfides 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡